Population
Patients with CNS disorders characterized by neuronal hyperexcitability, such as migraine, epilepsy and…
Design
Review
Authors
Loading...
Should not change practice in CNS hyperexcitability disorders; leaves open need for randomized trials of KCNQ openers.
KCNQ potassium channel openers show potential as therapeutic agents for CNS disorders involving neuronal hyperexcitability.
Wua et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: